IL32 and lung cancer: Accordingly, an analysis of IL-32 immunoreactivity in lung cancer has shown that adenocarcinomas had strong overexpression of interleukin-positive cells while the most of squamous cell carcinoma samples were lacking IL32-immunoreactivity [33].